Combination of 35-Gene Mutation Profile and Radiotherapy Dosimetry Predicts the Therapeutic Outcome of Definitive Chemoradiation in Patients With Esophageal Squamous Cell Carcinoma

Esophageal cancer is a common malignancy worldwide and a leading cause of cancer-related mortality. Definitive concurrent chemoradiotherapy (CCRT) has been widely used to treat locally advanced esophageal squamous cell carcinoma (ESCC). In this study, we evaluated the predictive power of a 35-gene m...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Peng, Tan, Chen, Pang, Qingsong, Chi, Chih-Wen, Wang, Yuwen, Yuan, Zhiyong, Huang, Yu-Chuen, Chen, Yu-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430340/
https://www.ncbi.nlm.nih.gov/pubmed/34513706
http://dx.doi.org/10.3389/fonc.2021.729418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430340/
https://www.ncbi.nlm.nih.gov/pubmed/34513706
http://dx.doi.org/10.3389/fonc.2021.729418

Ejemplares similares